Skip to main content
TipRanks
Go Ultimate75% OFF

Alembic Pharmaceuticals Limited (APLLTD) Financial Statements

2 Followers

Alembic Pharmaceuticals Limited Financial Overview

Alembic Pharmaceuticals Limited's market cap is currently ₹202.40B. The company's EPS TTM is ₹42.92; its P/E ratio is 24.00; and it has a dividend yield of 1.16%. Alembic Pharmaceuticals Limited is estimated to report earnings on February 11, 2027, and the estimated EPS forecast is ₹10.35. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 73.45B₹ 66.72B₹ 62.29B₹ 56.53B₹ 53.06B
Gross Profit₹ 33.10B₹ 47.91B₹ 44.33B₹ 38.78B₹ 38.08B
Operating Income₹ 8.00B₹ 27.02B₹ 25.08B₹ 19.81B₹ 18.31B
EBITDA₹ 11.06B₹ 10.08B₹ 9.33B₹ 7.13B₹ 8.74B
Net Income₹ 6.75B₹ 5.83B₹ 6.16B₹ 3.42B₹ 5.21B
Balance Sheet
Cash & Short-Term Investments₹ 2.03B₹ 901.00M₹ 1.20B₹ 754.80M₹ 610.90M
Total Assets₹ 87.63B₹ 77.73B₹ 64.46B₹ 61.83B₹ 71.22B
Total Debt₹ 14.30B₹ 12.57B₹ 5.13B₹ 7.22B₹ 7.17B
Net Debt₹ 12.27B₹ 11.67B₹ 3.93B₹ 6.47B₹ 6.56B
Total Liabilities₹ 30.94B₹ 25.83B₹ 16.27B₹ 18.12B₹ 18.84B
Stockholders' Equity₹ 56.75B₹ 51.91B₹ 48.18B₹ 43.70B₹ 52.38B
Cash Flow
Free Cash Flow₹ 2.61B₹ -4.76B₹ 4.76B₹ 2.81B₹ 1.27B
Operating Cash Flow₹ 6.95B₹ 879.70M₹ 8.03B₹ 7.24B₹ 5.52B
Investing Cash Flow₹ -5.07B₹ -5.68B₹ -3.21B₹ -4.48B₹ -3.72B
Financing Cash Flow₹ -756.50M₹ 4.44B₹ -4.38B₹ -2.62B₹ -2.17B

Currency in INR

Alembic Pharmaceuticals Limited Earnings and Revenue History

030B60B90B0 %8 %16 %24 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin

Alembic Pharmaceuticals Limited Liabilities to Assets

040B80B120B20 %30 %40 %50 %LiabilitiesLiabilities to Assets2017201820192020202120222023202420252026AssetsLiabilitiesLiabilities to Assets

Alembic Pharmaceuticals Limited Cash Flow

-15B-10B-5B05B10B15B20B2017201820192020202120222023202420252026OperatingInvestingFinancing

Alembic Pharmaceuticals Limited Forecast EPS vs Actual EPS

68101214161820Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27EPS EstimateBeatMiss